Aromatase and interleukin-10 genetic variants interactively modulate Alzheimer's disease risk

Journal of Neural Transmission

Volumn 115, Issue 6, 2008, Pages 863-867

  Combarros, O ^a   Sanchez Juan P ^a   Riancho, J A ^b   Mateo, I ^a   Rodriguez Rodriguez E ^a   Infante, J ^a   Garcia Gorostiaga I ^a   Vazquez Higuera J L ^a   Berciano, J ^a  

^a HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^b UNIVERSITY OF CANTABRIA   (Spain)

Author keywords

Alzheimer's disease; Aromatase; Epistasis; Interleukin 10; Polymorphism

Indexed keywords

AROMATASE; INTERLEUKIN 10;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DISEASE PREDISPOSITION; DNA POLYMORPHISM; FEMALE; GENETIC CODE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RISK FACTOR;

5' UNTRANSLATED REGIONS; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AROMATASE; BRAIN; BRAIN CHEMISTRY; CASE-CONTROL STUDIES; DNA MUTATIONAL ANALYSIS; ESTROGENS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; INTERLEUKIN-10; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, GENETIC; VARIATION (GENETICS);

EID: 44949156562     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-008-0028-5     Document Type: Article

References (17)

1. Arosio B, Trabattoni D, Galimberti L, Bucciarelli P, Fasano F, Calabresi C, Cazzullo CL, Vergani C, Annoni G, Clerici M (2004) Interleukin-10 and interleukin-6 gene polymorphisms as risk factors for Alzheimeŕs disease. Neurobiol Aging 25:1009-1015
2. Combarros O, Riancho JA, Infante J, Sañudo C, Llorca J, Zarrabeitia MT, Berciano J (2005) Interaction between CYP19 aromatase and butyrylcholinesterase genes increases Alzheimer's disease risk. Dement Geriatr Cogn Disord 20:153-157
3. Dimayuga FO, Reed JL, Carnero GA, Wang C, Dimayuga ER, Dimayuga VM, Perger A, Wilson ME, Keller JN, Bruce-Keller AJ (2005) Estrogen and brain inflammation: effects on microglial expression of MHC, costimulatory molecules and cytokines. J Neuroimmunol 161:123-136
4. Henderson VW (2006) Estrogen-containing hormone therapy and Alzheimer's disease risk: understanding discrepant inferences from observational and experimental research. Neuroscience 138:1031-1039
5. Huang R, Poduslo SE (2006) CYP19 haplotypes increase risk for Alzheimer's disease. J Med Genet 43:e42
6. Iivonen S, Corde E, Lehtovirta M, Helisalmi S, Mannermaa A, Vepsäläinen S, Hänninen T, Soininen H, Hiltunen M (2004) Polymorphisms in the CYP19 gene confer increased risk for Alzheimer disease. Neurology 62:1170-1176
7. Ishunina TA, Fischer DF, Swaab DF (2007) Estrogen receptor α and its splice variants in the hippocampus in aging and Alzheimer's disease. Neurobiol Aging 28:1670-1681
8. Lio D, Licastro F, Scola L, Chiappelli M, Grimaldi LM, Crivello A, Colonna-Romano G, Candore G, Franceschi C, Caruso C (2003a) Interleukin-10 promoter polymorphism in sporadic Alzheimer's disease. Genes Immun 4:234-238
9. Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafe M, Cavallone L, Marchegiani F, Olivieri F, Franceschi C, Caruso C (2003b) Inflammation, genetics, and longevity: further studies on the protective effects in men of IL-10 -1082 promoter SNP an dits interaction with TNF-α -308 promoter SNP. J Med Genet 40:296-299
10. McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer disease: report of the NINCDS-ADRDA Work Group under the auspices of the Department of Health and Human Services Task Force on Alzheimer Disease. Neurology 24:939-944
11. Stoffel-Wagner B, Watzka M, Schramm J, Bidlingmaier F, Klingmüller D (1999) Expression of CYP19 (aromatase) mRNA in different areas of the human brain. J Steroid Biochem Mol Biol 70:237-241
12. Strle K, Zhou JH, Shen WH, Broussard SR, Johnson RW, Freund GG, Dantzer R, Kelley KW (2001) Interleukin-10 in the brain. Crit Rev Immunol 21:429-449
13. Vegeto E, Belcredito S, Ghisletti S, Meda C, Etteri S, Maggi A (2006) The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation. Endocrinology 147:2263-2272
14. Wiss-Coray T, Mucke L (2002) Inflammation in neurodegenerative disease: a double-edged sword. Neuron 35:419-432
15. Yue X, Lu M, Lancaster T, Cao P, Honda S, Staufenbiel M, Harada N, Zhong Z, Shen Y, Li R (2005) Brain estrogen deficiency accelerates Aβ plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci USA 102:19198-19203
16. Zarrabeitia MT, Hernández JL, Valero C, Zarrabeitia AL, García-Unzueta M, Amado JA, González-Macías J, Riancho JA (2004a) A common polymorphism in the 5́-untranslated region of the aromatase gene influences bone mass and fracture risk. Eur J Endocrinol 150:699-704
17. Zarrabeitia A, Zarrabeitia MT, Valero C, González-Macías J, Riancho JA (2004b) Age-related influence of common aromatase gene polymorphisms on bone mass of healthy men. Bone 35:243-248